NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Abselion

Abselion

Private
CambridgeHealthcare & Life Scienceshttps://www.abselion.com/

Last Round

Series A

Dec 4, 2024

Total Funding Raised

$11.05M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Abselion is a life sciences tools company that develops and manufactures automated analytical instruments for protein quantification.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales

AI Layer

Non-AI

Keywords

gene therapyAAV quantificationviral vectorbioprocessingAdeno-Associated VirusAAVanalytical instrumentationbiotech toolsRedox Electrochemical DetectionREDbioprocess analyticsCDMOcontract manufacturingat-line monitoringbiotech lab tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Abselion Comparables

Compare Abselion with similar companies based on industry and business-model similarity.

Abselion comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Refeyn
79%
Mesa Laboratories Inc
74%
Thermo Fisher Scientific Inc.
73%

Abselion Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 4, 2024
SeedApr 20, 2021
GrantSep 11, 2018

Key People

Founding team and executive leadership

Ruizhi Wang

Founder And CEO

Founding Team

Abselion Investors

Notable investors and investment history

Abselion investors
InvestorRounds
NG BioSeed
Swiss Health AngelsSeed
The Untitled venturesSeries A
BGFSeries A
M VenturesSeries A
Cambridge EnterpriseSeed
R42 GroupSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 23, 2026

    Dale Gordon appointed as Chair of the Board of Directors.

  • Mar 18, 2026

    Developing Amperia protein quantification system with international interest.

Abselion Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Abselion Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Abselion's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range27
Year Founded2018
Last FundingDec 4, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.